Huapont Life SciencesLtd Balance Sheet Health
Financial Health criteria checks 5/6
Huapont Life SciencesLtd has a total shareholder equity of CN¥16.5B and total debt of CN¥9.3B, which brings its debt-to-equity ratio to 56.8%. Its total assets and total liabilities are CN¥31.1B and CN¥14.6B respectively. Huapont Life SciencesLtd's EBIT is CN¥1.1B making its interest coverage ratio 3.6. It has cash and short-term investments of CN¥4.2B.
Key information
56.8%
Debt to equity ratio
CN¥9.34b
Debt
| Interest coverage ratio | 3.6x |
| Cash | CN¥4.24b |
| Equity | CN¥16.45b |
| Total liabilities | CN¥14.61b |
| Total assets | CN¥31.06b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 002004's short term assets (CN¥11.8B) exceed its short term liabilities (CN¥10.6B).
Long Term Liabilities: 002004's short term assets (CN¥11.8B) exceed its long term liabilities (CN¥4.0B).
Debt to Equity History and Analysis
Debt Level: 002004's net debt to equity ratio (31%) is considered satisfactory.
Reducing Debt: 002004's debt to equity ratio has reduced from 76.3% to 56.8% over the past 5 years.
Debt Coverage: 002004's debt is not well covered by operating cash flow (16.1%).
Interest Coverage: 002004's interest payments on its debt are well covered by EBIT (3.6x coverage).